Tiopronin Patent Expiration
Tiopronin is Used for preventing cystine stone formation in individuals with severe homozygous cystinuria. It was first introduced by Mission Pharmacal Co
Tiopronin Patents
Given below is the list of patents protecting Tiopronin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Thiola Ec | US11458104 | Enteric coated tiopronin tablet | Nov 14, 2038 | Mission Pharmacal |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Tiopronin's patents.
Latest Legal Activities on Tiopronin's Patents
Given below is the list recent legal activities going on the following patents of Tiopronin.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Recordation of Patent Grant Mailed Critical
| 04 Oct, 2022 | US11458104 |
| Application ready for PDX access by participating foreign offices Critical
| 04 Oct, 2022 | US11458104 |
| Patent Issue Date Used in PTA Calculation Critical
| 04 Oct, 2022 | US11458104 |
| Email Notification Critical
| 15 Sep, 2022 | US11458104 |
| Issue Notification Mailed Critical
| 14 Sep, 2022 | US11458104 |
| Dispatch to FDC | 12 Sep, 2022 | US11458104 |
| Application Is Considered Ready for Issue Critical
| 12 Sep, 2022 | US11458104 |
| Email Notification Critical
| 05 Aug, 2022 | US11458104 |
| Mailing Corrected Notice of Allowability | 05 Aug, 2022 | US11458104 |
| Corrected Notice of Allowability | 01 Aug, 2022 | US11458104 |
Tiopronin's Family Patents
